STERIS plc
STENYSE · SIC 3842
$217.84
↓ -1.5%Jul 17 close · end-of-day
Price
1Y↓ -3.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$21.5B
Enterprise Value
$23.4B
P/E
27.5
P/S
3.6
P/B
3.0
EV/EBITDA
14.8
PEG
0.3
FCF Yield
4.5%
Dividend Yield
1.1%
Revenue (TTM)
$5.9B
Net Income (TTM)
$782.3M
Free Cash Flow (TTM)
$972.4M
Gross Margin
44.3%
Operating Margin
18.6%
Net Margin
13.2%
ROE
10.9%
ROIC
9.1%
Debt / Equity
0.3
Net Cash
-$1.9B
Return 1Y
-2.0%
Company profile
Management & directors
- Zangerle John AdamSr. VP, Gen Counsel, and Sec.
- Carestio Daniel APresident and CEO
- Burton Karen LSr. Vice Pres., CFO
- Fraser Mary ClareSVP & Chief HRO
- Kohler Kenneth ESVP & GM, AST
- Madsen JuliaSr. VP and GM, Life Sciences
- Tamaro RenatoV.P. & Corporate Treasurer
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-08-10
STE Q4 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.6B↑ +7.3%
Diluted EPS$2.24↑ +51.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $4.2B | $4.5B | $5.1B | $5.5B | $5.9B |
| Gross profit | $1.3B | $1.9B | $2.0B | $2.2B | $2.4B | $2.6B |
| Operating income | $548.4M | $477.8M | $791.1M | $836.1M | $866.6M | $1.1B |
| Net income | $397.4M | $243.9M | $107.0M | $378.2M | $614.6M | $782.3M |
| Diluted EPS | $4.63 | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |
| Operating cash flow | $689.6M | $684.8M | $756.9M | $973.3M | $1.1B | $1.3B |
| Free cash flow | $450.4M | $397.2M | $395.0M | $613.0M | $778.0M | $972.4M |
| Gross margin | 43.2% | 44.6% | 43.7% | 43.2% | 44.0% | 44.2% |
| Operating margin | 17.6% | 11.3% | 17.4% | 16.3% | 15.9% | 18.6% |
| Net margin | 12.8% | 5.8% | 2.4% | 7.4% | 11.3% | 13.2% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.4B | $1.5B | $1.4B | $1.5B | $1.5B | $1.6B |
| Gross profit | $572.4M | $578.8M | $610.3M | $641.3M | $628.0M | $645.9M | $655.5M | $697.1M |
| Operating income | $185.5M | $219.7M | $245.3M | $216.1M | $246.0M | $265.8M | $273.2M | $316.8M |
| Net income | $145.4M | $150.0M | $173.5M | $145.7M | $177.4M | $191.9M | $192.9M | $220.1M |
| Diluted EPS | $1.46 | $1.51 | $1.75 | $1.48 | $1.79 | $1.94 | $1.96 | $2.24 |
| Operating cash flow | $303.7M | $250.8M | $332.8M | $260.8M | $420.0M | $287.8M | $298.2M | $335.4M |
| Free cash flow | $195.6M | $148.9M | $243.6M | $189.9M | $326.4M | $201.3M | $199.5M | $245.2M |
| Gross margin | 44.7% | 43.6% | 44.5% | 43.3% | 45.1% | 44.2% | 43.8% | 43.9% |
| Operating margin | 14.5% | 16.5% | 17.9% | 14.6% | 17.7% | 18.2% | 18.3% | 19.9% |
| Net margin | 11.4% | 11.3% | 12.7% | 9.8% | 12.8% | 13.1% | 12.9% | 13.9% |
Company news
Coming soonHeadlines for STE will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Sohi Mohsen | Tax withholding | 1,837 | $212.30 | $389,995.10 | filing |
| 2026-07-01 | Sohi Mohsen | Option exercise | 3,781 | $71.40 | $269,963.40 | filing |
| 2026-06-15 | Zangerle John Adam· Sr. VP, Gen Counsel, and Sec. | Sale | 1,419 | $209.28 | $296,968.32 | filing |
| 2026-06-05 | Carestio Daniel A· President and CEO | Sale | 1,374 | $212.00 | $291,288.00 | filing |
| 2026-06-04 | Carestio Daniel A· President and CEO | Sale | 3,054 | $214.64 | $655,510.56 | filing |
| 2026-06-04 | Carestio Daniel A· President and CEO | Tax withholding | 1,889 | $212.24 | $400,921.36 | filing |
| 2026-06-04 | Fraser Mary Clare· SVP & Chief HRO | Tax withholding | 600 | $212.24 | $127,344.00 | filing |
| 2026-06-04 | Zangerle John Adam· Sr. VP, Gen Counsel, and Sec. | Tax withholding | 401 | $212.24 | $85,108.24 | filing |
| 2026-06-04 | Madsen Julia· Sr. VP and GM, Life Sciences | Tax withholding | 195 | $212.24 | $41,386.80 | filing |
| 2026-06-04 | Kohler Kenneth E· SVP & GM, AST | Tax withholding | 150 | $212.24 | $31,836.00 | filing |
| 2026-06-04 | Burton Karen L· Sr. Vice Pres., CFO | Tax withholding | 90 | $212.24 | $19,101.60 | filing |
| 2026-06-04 | Tamaro Renato· V.P. & Corporate Treasurer | Tax withholding | 65 | $212.24 | $13,795.60 | filing |
| 2026-06-03 | Zangerle John Adam· Sr. VP, Gen Counsel, and Sec. | Tax withholding | 365 | $210.19 | $76,719.35 | filing |
| 2026-06-03 | Madsen Julia· Sr. VP and GM, Life Sciences | Tax withholding | 239 | $210.19 | $50,235.41 | filing |
| 2026-06-03 | Tamaro Renato· V.P. & Corporate Treasurer | Tax withholding | 64 | $210.19 | $13,452.16 | filing |
Latest 15 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.